Mesotherapy-The french connection

Journal of Pharmacology and Pharmacotherapeutics

Volumn 1, Issue 1, 2010, Pages 4-8

  Sivagnanam, G ^a  

^a INDIRA GANDHI MEDICAL COLLEGE   (India)

Author keywords

Body sculpting; cellulite; injection lipolysis; intradermotherapy; nappage

Indexed keywords

BACLOFEN; DIAZEPAM; FINASTERIDE; KETOROLAC; LIDOCAINE; LIOTHYRONINE; MINOXIDIL; MULTIVITAMIN; PIROXICAM; PROCAINE; RECOMBINANT FOLLITROPIN; SALCATONIN; THYROXINE;

ACUPUNCTURE; ADVERSE OUTCOME; ALOPECIA; ANALGESIA; ASTHMA; BACTERIAL SKIN DISEASE; BONE PAIN; CHRONIC PAIN; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; DELAYED HYPERSENSITIVITY; DIARRHEA; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; FRANCE; HISTORY OF MEDICINE; HUMAN; HYPERESTHESIA; IMMEDIATE TYPE HYPERSENSITIVITY; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; LIPOLYSIS; MACULOPAPULAR RASH; MESOTHERAPY; MINIMALLY INVASIVE PROCEDURE; MYCOBACTERIOSIS; NAUSEA AND VOMITING; NONHUMAN; PAIN; PAIN ASSESSMENT; PATIENT SAFETY; REJUVENATION; REVIEW; SCAR FORMATION; SUBCUTANEOUS NODULE; TISSUE NECROSIS; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; URTICARIA PIGMENTOSA;

EID: 84865587881     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.64529     Document Type: Review

References (38)

1. Le Coz J 2005 History of Mesotherapy. Available from: http://www. mesotherapyworldwide.com/images/pdf/AJM-Vol-3-200511-40.pdf [Accessed on 2009 Nov 21].
2. Rotunda A, Kolodney MS. Mesotherapy and phosphatidylcholine injections: Historical clarification and review. Dermatol Surg 2006;32:465-80.
3. Kaplan, Raincourt. Devenir d'un produit marque injecte par quatre voies differentes. Bulletin SFM (la Societe Francaise de Mesotherapie) 1985:62. A product brand injected in four different ways. Bulletin SFM (The French Society of Mesotherapy)
4. Pistor M. What is mesotherapy? Chir Dent Fr 1976;46:59-60.
5. Matarasso A, Pfeifer TM, Plastic Surgery Educational Foundation DATA Committee. Mesotherapy for body contouring. Plast Reconstr Surg 2005;115:1420-4.
6. Pistor M. Un defi therapeutique. la mesotherapie. 3rd ed. Paris, France: Malonie; 1979.
7. FDA Statement on Lipo-Dissolve 2008. Available from: http://www.cbs46. com/print/15186454/detail.html [Accessed on 2009 Nov 21].
8. Weaver KA and Figura J. Mesotherapy and the Off-Label Use of Approved Drugs. Available from: http://www.mesotherapyworldwide.com/images/pdf/AJM-Vol-4- 2006-58.pdf [Accessed on 2009 Nov 21].
9. American society of plastic surgeons. ASPS Guiding Principles for Mesotherapy/Injection Lipolysis, 2008. Available from: http://www. plasticsurgery.org/Documents/Medical-Profesionals/Health-Policy/ ASPS-Guiding-Principles-for-Mesotherapy-Injection-Lipolysis-7-08.pdf [Accessed on 2009 Nov 22].
10. Palermo S, Riello R, Cammardella MP, Carossino D, Orlandini G, Casigliani R, et al. TENS + mesotherapy association in the therapy of cervico-brachialgia: Preliminary data. Minerva Anestesiol 1991;57:1084-5.
11. Menkes CJ, Laoussadi S, Kac-Ohana N, Lasserre O. Controlled trial of injectable diclofenac in mesotherapy for the treatment of tendinitis. Rev Rhum Mal Osteoartic 1990;57:589-91. (Pubitemid 20379673)
12. Medioni G. Orodental mesotherapy. Chir Dent Fr 1976;46:97-102.
13. Lyritis GP, Trovas G. Analgesic effects of calcitonin. Bone 2002;30:71S-74S. (Pubitemid 34465712)
14. Adelson H. French Mesotherapy for the Treatment of Pain. Available from http://www.mesotherapyworldwide.com/images/pdf/AJM-Vol-4-2006-57. pdf [Accessed on 2009 Nov 21].
15. Vale ML, Benevides VM, Sachs D, Brito GA, da Rocha FA, Poole S, et al. Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain. Br J Pharmacol 2004;143:833-44. (Pubitemid 39664842)
16. Leibaschoff G. Mesotherapy and Cellulite. American journal of Mesotherapy 2006;4:53.
17. Leibaschoff G. Mesotherapy and Cellulite. American journal of Mesotherapy 2006;4:53 Available from http://www.mesotherapyworldwide.com/images/pdf/AJM- Vol-4-2006-53.pdf [Accessed on 2009 Nov 21].
18. Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004;30:1001-8. (Pubitemid 38890909)
19. Rittes PG. Stretch marks-Striae. American journal of Mesotherapy 2005;3:11-36.
20. Rittes PG. Stretch marks-Striae. Am J Mesother 2005;3:11 36 Available from http://www.mesotherapyworldwide.com/images/pdf/AJM-Vol-3-200511-36.pdf [Accessed on 2009 Nov 21].
21. Bryant R. Controversial mesotherapy: Could it be the next Botox? Derm Times 2004;25:1.
22. Bryant R. Controversial mesotherapy: Could it be the next Botox? Derm Times 2004;25:1. Available from http://www.modernmedicine. com/modernmedicine/ article/articleDetail.jsp?id=137281 [Accessed on 2009 Nov 21].
23. Extract from mesotherapyedmonton.com Available from: http://mesotherapy0. tripod.com/id4.html [Accessed on 2009 Nov 21].
24. Capuano DJ. Mesotherapy: An Update. 2004. Available from: http://www. capuanousa.com/plastic/meso/meso2004.htm [Accessed on 2009 Nov 23].
25. Lacarrubba F, Tedeschi A, Nardone B, Micali G. Mesotherapy for skin rejuvenation: Assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatologic Therapy 2008;21:S1-5.
26. Hsu CC, Hsu CT. Conception using vaginal administration of gonadotrophins in IVF: A case report. Reprod Biomed Online 2006;12:170-3.
27. Le Coz J. Mesotherapy and Lipolysis: A comprehensive clinical approach. 1st ed. Mesotherapy and Lipolysis: A comprehensive clinical approach Singapore: National Library Board; 2008.
28. Tanrikulu L. Mesotherapy: Medical education. Turk Klinikleri J Med Sci 2007;27:272-5. (Pubitemid 47164370)
29. Tanrikulu L. Mesotherapy: Medical education. Turk Klinikleri J Med Sci 2007;27:272-5. Translated version available from http://www.turkiyeklinikleri. com/abstract-tr.php?id=47495 [Accessed on 2009 Nov 21]. (Pubitemid 47164370)
30. Le Coz J and Rittes PG. Guidelines and limitations on the use of phosphatidylcholine (lipostabil) in mesotherapy. Available from: http://www. mesotherapyworldwide.com/images/pdf/Vol-2-20-GUIDELINES.pdf. [Accessed on 2009 Nov 21].
31. Chase CC. Common complications and adverse reactions in a mesotherapy Practice. 2005. Available from: http://www.mesotherapyworldwide.com/images/pdf/ AJM-Vol-1-200510-8.pdf. [Accessed on 2009 Nov 23].
32. Sañudo A, Vallejo F, Sierra M, Hoyos JG, Yepes S, Wolff JC, et al. Nontuberculous mycobacteria infection after mesotherapy: Preliminary report of 15 cases. Int J Dermatol 2007;46:649-53. (Pubitemid 46909413)
33. Contraindications to mesotherapy. Available from: https://www. internetmedicalclinics.com/pdfs/meso-eng.pdf [Accessed on 2009 Nov 21].
34. Rohrich RJ. Mesotherapy: what is it? Does it work? Plast Reconstr Surg 2005;115:1425. (Pubitemid 40489806)
35. Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: A clinical, histologic, and electron microscopic evaluation. Dermatol Surg 2006;32:1467-72. (Pubitemid 44934895)
36. Dobradin A. Annual subscription request. Available from: http://www. mesotherapyworldwide.com/images/pdf/Vol-7-112-MesoandFlaccidity.pdf [Accessed on 2009 Nov 23].
37. American Academy of Aesthetic Medicine. Available from: http://www. mesotherapyworldwide.com/Mesotherapy-Training.htm#AMER [Accessed on 2009 Nov 23].
38. Atiyeh BS, Ibrahim AE, Dibo SA. Cosmetic Mesotherapy: Between scientific evidence, science fiction, and lucrative business. Aesthetic Plast Surg 2008;32:842-9.